its use is restricted within the allergic asthma subtype. The treatment of an already established exacerbation is more straight forward than its prevention. It comprises of oxygenation ...

A study published in JAMA reports on data showing that Combination ICS-SABA and ICS-Formoterol asthma treatments are more effective than SAMA-only treatment. Details of the study were presented in ...

USA: Recent findings published in The Journal of Allergy and Clinical Immunology highlight the potential for long-term ...

Rationale Progressive lung function (LF) decline in patients with asthma contributes to worse outcomes. Asthma exacerbations are thought to contribute to this decline; however, evidence is limited ...

stepping-up to high-dose ICS was not associated with benefit in preventing future exacerbations,” the investigators concluded. The study authors wrote, “Other treatment strategies may prove to be ...

BOSTON -- Inhaled corticosteroids (ICS) combined either with formoterol (Foradil) or short-acting beta-agonists (SABA) for asthma treatment were associated with reduced risks of severe exacerbations ...

The FDA approval of Airsupra permits use for as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in people with asthma aged 18 years and older.

Conclusion and recommendation: Only around forty-two percent of study participants were autonomous in managing their asthma exacerbation. Thus healthcare providers should give ... encouraging decision ...

Asthma is a chronic inflammatory disease affecting the airways of the lungs. When triggered, asthma causes episodic attacks characterized by bronchospasms (spasms of the airways), bronchoconstriction ...